These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35623883)

  • 1. Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice Guideline.
    Murayama A; Yamada K; Yoshida M; Kaneda Y; Saito H; Sawano T; Shrestha S; Shrestha R; Tanimoto T; Ozaki A
    Clin J Am Soc Nephrol; 2022 Jun; 17(6):819-826. PubMed ID: 35623883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors' Self-Citation Rate in Japan and the United States.
    Mamada H; Murayama A; Kamamoto S; Kaneda Y; Yoshida M; Sugiura S; Yamashita E; Kusumi E; Saito H; Sawano T; Tanimoto T; Vassar M; Ozieranski P; Ozaki A
    Arthritis Care Res (Hoboken); 2023 Jun; 75(6):1278-1286. PubMed ID: 36194077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conflicts of Interest Among Cardiology Clinical Practice Guideline Authors in Japan.
    Murayama A; Aizawa M; Byreddy KR; Higuchi K; Senoo Y
    J Am Heart Assoc; 2024 Apr; 13(8):e034506. PubMed ID: 38606773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan.
    Yamamoto K; Murayama A; Ozaki A; Saito H; Sawano T; Tanimoto T
    Int Urogynecol J; 2021 Feb; 32(2):443-451. PubMed ID: 33151353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines.
    Murayama A; Kamamoto S; Murata N; Yamasaki R; Yamada K; Yamashita E; Saito H; Tanimoto T; Ozaki A
    J Gastroenterol Hepatol; 2023 Apr; 38(4):565-573. PubMed ID: 36518089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.
    Saito H; Ozaki A; Sawano T; Shimada Y; Tanimoto T
    JAMA Netw Open; 2019 Apr; 2(4):e192834. PubMed ID: 31026027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial and Intellectual Conflicts of Interest Among Japanese Clinical Practice Guidelines Authors for Allergic Rhinitis.
    Murayama A; Kida F; Ozaki A; Saito H; Sawano T; Tanimoto T
    Otolaryngol Head Neck Surg; 2022 May; 166(5):869-876. PubMed ID: 34399654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.
    Checketts JX; Sims MT; Vassar M
    JAMA Dermatol; 2017 Dec; 153(12):1229-1235. PubMed ID: 29049553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019.
    Murayama A; Kamamoto S; Kawashima M; Saito H; Yamashita E; Tanimoto T; Ozaki A
    BMJ Open; 2023 Apr; 13(4):e068237. PubMed ID: 37072354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional analysis of pharmaceutical industry payments to authors of clinical practice guidelines for bipolar disorder and major depressive disorder in Japan.
    Murayama A; Kugo H; Senoo Y
    BMJ Open; 2024 Jun; 14(6):e086396. PubMed ID: 38908845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Industry Relationships Among Authors of Otolaryngology Clinical Practice Guidelines.
    Horn J; Checketts JX; Jawhar O; Vassar M
    JAMA Otolaryngol Head Neck Surg; 2018 Mar; 144(3):194-201. PubMed ID: 29270633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial conflicts of interest between pharmaceutical companies and executive board members of internal medicine subspecialty societies in Japan between 2016 and 2020.
    Murayama A; Saito H; Tanimoto T; Ozaki A
    J Eval Clin Pract; 2023 Sep; 29(6):883-886. PubMed ID: 37283452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial payments made by pharmaceutical companies to the authors of Japanese hematology clinical practice guidelines between 2016 and 2017.
    Harada K; Ozaki A; Saito H; Sawano T; Yamamoto K; Murayama A; Senoo Y; Tanimoto T
    Health Policy; 2021 Mar; 125(3):320-326. PubMed ID: 33386174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial Conflicts of Interest Among Authors of Urology Clinical Practice Guidelines.
    Carlisle A; Bowers A; Wayant C; Meyer C; Vassar M
    Eur Urol; 2018 Sep; 74(3):348-354. PubMed ID: 29747945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan.
    Murayama A; Ozaki A; Saito H; Sawano T; Shimada Y; Yamamoto K; Suzuki Y; Tanimoto T
    PLoS One; 2020; 15(10):e0239610. PubMed ID: 33048952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan.
    Sawano T; Ozaki A; Saito H; Shimada Y; Tanimoto T
    JAMA Netw Open; 2019 May; 2(5):e193817. PubMed ID: 31099864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross-sectional analysis of personal payments from pharmaceutical companies between 2016 and 2019.
    Kamamoto S; Murayama A; Kusumi E; Yoshida M; Saito H; Sawano T; Yamashita E; Tanimoto T; Ozaki A
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29891. PubMed ID: 35949170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Financial contributions to guideline group members from industry: An analysis based on the US Open Payments database].
    Anjos DRD; Eisch E; Mathes T
    Z Evid Fortbild Qual Gesundhwes; 2020 Aug; 153-154():39-43. PubMed ID: 32553895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of non-research payments from pharmaceutical companies to urologists in Japan between 2016 and 2019.
    Murayama A; Saito H; Kamamoto S; Shigeta H; Yamashita E; Tanimoto T; Ozaki A
    Int Urogynecol J; 2023 Jun; 34(6):1285-1292. PubMed ID: 36723634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Financial Conflicts of Interest Among Physician-Authors of American College of Rheumatology Clinical Practice Guidelines.
    Wayant C; Walters C; Zaaza Z; Gilstrap C; Combs T; Crow H; Vassar M
    Arthritis Rheumatol; 2020 Sep; 72(9):1427-1434. PubMed ID: 32039569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.